Abstract 2239: FB849, a highly selective HPK1 inhibitor, reshapes the tumor immune microenvironment by modulating various immune cells
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institution: Korea Advanced Institute of Science and Technology
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409629329
